Gabrielle Sulzberger
CIK 1262388 · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.43M
Companies
12
Total Filings
124
Lifetime Open-Market Net
-$2.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LLY | Director | 2,986 | $1133.00 | $3.38M | $75.0K | 55 | 2026-05-19 |
| MA | Director | 5,336 | $489.98 | $2.61M | $0 | 8 | 2025-06-26 |
| WRBY | Director | 84,024 | $26.46 | $2.22M | -$1.09M | 5 | 2024-06-11 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 58,876 | $44.96 | $2.65M | $0 | 4 | 2024-06-07 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | 49,624 | $18.07 | $896.7K | $275.4K | 3 | 2021-06-24 |
| BRX | Director | 37,161 | $32.58 | $1.21M | $36.6K | 8 | 2021-06-01 |
| WHOLE FOODS MARKET INC (WFM) Delisted | Director | 0 | — | — | -$1.33M | 21 | 2017-08-28 |
| STAGE STORES INC (SSI) Delisted | Director | 21,574 | — | — | $0 | 3 | 2013-06-17 |
| WHOLE FOODS MARKET INC (WFMI) Delisted | Director | 4,829 | — | — | -$767.1K | 11 | 2011-02-11 |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC (GGA) Delisted | Director | — | — | — | $0 | 1 | 2008-05-28 |
| INDYMAC BANCORP INC (IMBp) Delisted | 4,443 | — | — | $8.1K | 1 | 2008-03-19 | |
| INDYMAC BANCORP INC (NDEp) Delisted | 2,828 | — | — | $0 | 2 | 2007-03-27 |
Recent Filings · Page 3 of 13
124 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-20 | LLY | Grant (A) | +316 | $229.9K | EDGAR |
| 2024-10-22 | LLY | Grant (A) | +11 | $10.0K | EDGAR |
| 2024-09-17 | LLY | Grant (A) | +11 | $10.2K | EDGAR |
| 2024-08-20 | LLY | Grant (A) | +11 | $10.1K | EDGAR |
| 2024-08-05 | — | Disp (D) | −58,876 | $0 | |
| 2024-07-16 | LLY | Grant (A) | +10 | $9.5K | EDGAR |
| 2024-06-21 | MA | Grant (A) | +545 | $0 | EDGAR |
| 2024-06-18 | LLY | Grant (A) | +11 | $9.7K | EDGAR |
| 2024-06-11 | WRBY | Grant (A) | +14,793 | $0 | EDGAR |
| 2024-06-07 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | +10,461 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.